India authorized two COVID-19 vaccines today for emergency use.
One was developed by Oxford University and U.K.-based drugmaker AstraZeneca and the other was developed by the Indian company Bharat Biotech.
Both vaccines are administered in two dosages.
The approvals pave the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country with the second highest total number of cases in the world: more than 10 million.
Additional reporting by Aniruddha Ghosal and Sheikh Saaliq of The Associated Press.